An Outperforming Fund Ditched Novavax And Picked Up These 3 Biotech Stocks

Perceptive Life Sciences, a fund that has outperformed the market, sold all of its 1 million shares of Novavax in the first few months of 2021 and bought millions more shares of three biopharma/biotech stocks in the same period, according to a restated form the investment firm behind the fund filed with the Securities and Exchange Commission. For a look at the three stocks it bought, CLICK HERE.